Could a common Alzheimer's drug fight prostate cancer?
NCT ID NCT07164794
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 21 times
Summary
This study tests whether memantine hydrochloride, a drug typically used for Alzheimer's, can help control advanced prostate cancer that has stopped responding to standard treatments. About 15 men with metastatic castration-resistant prostate cancer will take the drug alongside their usual therapy. Researchers will monitor cancer progression, PSA levels, and disease control over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.